| Summary of calculation of diluted net income (loss) per share, the numerator is adjusted for any changes |
For the three and six months ended June 30, 2026 and 2025, the Company’s potentially dilutive securities, which include stock options, RSUs, warrants and pre-funded warrants have been excluded from the computation of diluted net loss per share as the effect would be to reduce the net loss per share.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
June 30, |
|
|
Six Months Ended
June 30, |
|
(in thousands, except per share amounts) |
|
2026 |
|
|
2025 |
|
|
2026 |
|
|
2025 |
|
Numerator: |
|
|
|
|
|
|
|
|
|
|
|
|
Net loss-basic |
|
$ |
(8,946 |
) |
|
$ |
(9,489 |
) |
|
$ |
(16,555 |
) |
|
$ |
(20,520 |
) |
Net loss-diluted |
|
$ |
(8,946 |
) |
|
$ |
(9,489 |
) |
|
$ |
(16,555 |
) |
|
$ |
(20,520 |
) |
Denominator: |
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average common shares outstanding-basic |
|
|
20,342,345 |
|
|
|
12,197,615 |
|
|
|
17,265,864 |
|
|
|
12,197,615 |
|
Dilutive securities |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Weighted-average common shares outstanding-diluted |
|
|
20,342,345 |
|
|
|
12,197,615 |
|
|
|
17,265,864 |
|
|
|
12,197,615 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss per share-basic |
|
$ |
(0.44 |
) |
|
$ |
(0.78 |
) |
|
$ |
(0.96 |
) |
|
$ |
(1.68 |
) |
Net loss per share-diluted |
|
$ |
(0.44 |
) |
|
$ |
(0.78 |
) |
|
$ |
(0.96 |
) |
|
$ |
(1.68 |
) |
|
| Summary of computation of diluted net loss per share attributable to common stockholders |
The Company excluded the following from the computation of diluted net loss per share attributable to common stockholders because including them would have had an anti-dilutive effect:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
June 30, |
|
|
Six Months Ended
June 30, |
|
|
|
2026 |
|
|
2025 |
|
|
2026 |
|
|
2025 |
|
Options to purchase common stock |
|
|
2,252,380 |
|
|
|
1,900,088 |
|
|
|
2,252,380 |
|
|
|
1,900,088 |
|
Restricted stock units |
|
|
599,326 |
|
|
|
464,450 |
|
|
|
599,326 |
|
|
|
464,450 |
|
Warrants to purchase common stock |
|
|
18,144 |
|
|
|
18,144 |
|
|
|
18,144 |
|
|
|
18,144 |
|
Pre-funded warrants to purchase common stock |
|
|
1,175,654 |
|
|
|
— |
|
|
|
1,175,654 |
|
|
|
— |
|
|